{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T08:29:08Z","timestamp":1768120148513,"version":"3.49.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Purpose:<\/jats:bold> Carpal tunnel syndrome (CTS) is a common form of median nerve compression in the wrist caused by focal peripheral neuropathy. Platelet-rich plasma (PRP) therapy could improve the healing ability by exposing the injured tissues to high concentrations of autologous growth factors. Our study aims to compare all injective treatments for CTS and assess the efficacy and priority of PRP therapy.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We searched Medline, Embase, Web of Science, Cochrane databases, and <jats:ext-link>Clinicaltrial.gov<\/jats:ext-link> until 17 October 2022. We only included data from randomized controlled trials (RCTs) that evaluated PRP injection therapy or drug injection therapy. The included RCTs measured at least one of the following three outcomes with validated instruments: in the visual analog scale (VAS), symptom severity scale (SSS), and functional status scale (FSS).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Overall, 19 studies with 1,066 patients were included in this study. We used the SUCRA rankings to determine the merits of various therapies. In all, 5% dextrose injections were the best treatment strategy for the VAS (MD \u22121.22, 95% CI \u22122.66 to 0.23; SUCRA = 79.2%), followed by triamcinolone (high-dose) injections (MD \u22120.69, 95% CI \u22122.11 to 0.73; SUCRA = 62.7%) and PRP injections (MD \u22120.39, 95% CI \u22121.67 to 0.89; SUCRA = 60.0%). In the SSS, the most effective intervention was hydroxyprogesterone injections (MD \u22120.62, 95% CI \u22121.09 to \u22120.16; SUCRA = 91.0%). The SUCRA ranking of PRP was second only to steroids and estrogen (MD \u22120.39, 95% CI \u22120.60 to \u22120.18; SUCRA = 60.8%). In the FSS, the best regimen strategy was hydroxyprogesterone injections (MD 0.12, 95% CI \u22120.30 to 0.54; SUCRA = 99.5%), followed by triamcinolone (low-dose) injections (MD \u22120.02, 95% CI \u22120.54 to 0.49; SUCRA = 87.4%) and PRP injections (MD \u22120.26, 95% CI \u22120.43 to \u22120.09; SUCRA = 77.1%).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> PRP is an alternative choice for CTS treatment. PRP injection is second only to steroids and estrogen in the treatment efficacy of CTS, with a wide indication and safe outcome.<\/jats:p>","DOI":"10.3389\/fphar.2022.906075","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T04:32:16Z","timestamp":1668054736000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of platelet-rich plasma in the treatment of carpal tunnel syndrome: A network meta-analysis of different injection treatments"],"prefix":"10.3389","volume":"13","author":[{"given":"Pan","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saroj","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruikang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"B1","first-page":"6","article-title":"Carpal tunnel syndrome","volume":"77","author":"Aroori","year":"2008","journal-title":"Ulst. Med. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.7326\/0003-4819-159-5-201309030-00004","article-title":"Methylprednisolone injections for the carpal tunnel syndrome: A randomized, placebo-controlled trial","volume":"159","author":"Atroshi","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.282.2.153","article-title":"Prevalence of carpal tunnel syndrome in a general population","volume":"282","author":"Atroshi","year":"1999","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12891-015-0752-6","article-title":"Comparison between the effects of progesterone versus corticosteroid local injections in mild and moderate carpal tunnel syndrome: A randomized clinical trial","volume":"16","author":"Bahrami","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/sim.1162","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"21","author":"Begg","year":"2002","journal-title":"Stat. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1136\/jnnp.74.12.1674","article-title":"Clinical surveillance of carpal tunnel syndrome in two areas of the United Kingdom, 1991-2001","volume":"74","author":"Bland","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pmrj.12171","article-title":"Effectiveness of phonophoresis treatment in carpal tunnel syndrome: A randomized double-blind, controlled trial","volume":"12","author":"Boonhong","year":"2020","journal-title":"PM R."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pmrj.12171","article-title":"Effectiveness of phonophoresis treatment in carpal tunnel syndrome: A randomized double-blind, controlled trial","volume":"12","author":"Boonhong","year":"2020","journal-title":"PM R."},{"key":"B9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.apmr.2019.10.193","article-title":"Effectiveness of platelet-rich plasma injections for nonsurgical management of carpal tunnel syndrome: A systematic review and meta-analysis of randomized controlled trials","volume":"101","author":"Catapano","year":"2020","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.apmr.2020.12.025","article-title":"One-year efficacy of platelet-rich plasma for moderate-to-severe carpal tunnel syndrome: A prospective, randomized, double-blind, controlled trial","volume":"102","author":"Chen","year":"2021","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"B12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3233\/BMR-150477","article-title":"Comparison of the efficacy of lidocaine and betamethasone dipropionate in carpal tunnel syndrome injection","volume":"30","author":"Dernek","year":"2017","journal-title":"J. Back Musculoskelet. Rehabil."},{"key":"B13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/ar3914","article-title":"Platelet-rich plasma therapy - future or trend?","volume":"14","author":"Dhillon","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0974-2077.150734","article-title":"Principles and methods of preparation of platelet-rich plasma: A review and author's perspective","volume":"7","author":"Dhurat","year":"2014","journal-title":"J. Cutan. Aesthet. Surg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/PHM.0000000000001546","article-title":"Comparison of ultrasound-guided local ozone (O2-O3) injection versus corticosteroid injection in patients with mild to moderate carpal tunnel syndrome","volume":"100","author":"Forogh","year":"2021","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12031-011-9679-z","article-title":"Evidences for antinociceptive effect of 17-\u03b1-hydroxyprogesterone caproate in carpal tunnel syndrome","volume":"47","author":"Ginanneschi","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/term.2815","article-title":"Short\u2010term effectiveness of platelet\u2010rich plasma in carpal tunnel syndrome: A controlled study","volume":"13","author":"G\u00fcven","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.apmr.2020.06.018","article-title":"Comparison of corticosteroid injection dosages in mild to moderate idiopathic carpal tunnel syndrome: A randomized controlled trial","volume":"101","author":"Hsu","year":"2020","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"B19","first-page":"337","article-title":"Comparison of local steroid injection into carpal tunnel via proximal and distal approach in patients with carpal tunnel syndrome","volume":"112","author":"Kamanli","year":"2011","journal-title":"Bratisl. Lek. Listy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2340\/16501977-0990","article-title":"Triamcinolone acetonide vs procaine hydrochloride injection in the management of carpal tunnel syndrome: Randomized placebo-controlled study","volume":"44","author":"Karada\u015f","year":"2012","journal-title":"J. Rehabil. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/jcm11040950","article-title":"Update on efficacy of conservative treatments for carpal tunnel syndrome","volume":"11","author":"Karjalanen","year":"2022","journal-title":"J. Clin. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJMcp013018","article-title":"Clinical practice. Carpal tunnel syndrome","volume":"346","author":"Katz","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5435\/00124635-200906000-00008","article-title":"Treatment of carpal tunnel syndrome","volume":"17","author":"Keith","year":"2009","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/ph13030049","article-title":"Regenerative injections including 5% dextrose and platelet-rich plasma for the treatment of carpal tunnel syndrome: A systematic review and network meta-analysis","volume":"13","author":"Lin","year":"2020","journal-title":"Pharm. (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00590-018-2278-8","article-title":"Platelet-rich plasma injections for carpal tunnel syndrome: A systematic and comprehensive review","volume":"29","author":"Malahias","year":"2019","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1480","DOI":"10.1002\/term.2566","article-title":"Platelet-rich plasma ultrasound-guided injection in the treatment of carpal tunnel syndrome: A placebo-controlled clinical study","volume":"12","author":"Malahias","year":"2018","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"CD010071","DOI":"10.1002\/14651858.CD010071.pub310.1002\/14651858.CD010071.pub2","article-title":"Platelet-rich therapies for musculoskeletal soft tissue injuries","volume":"2014","author":"Moraes","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pmrj.2010.11.007","article-title":"Applications of platelet-rich plasma in musculoskeletal and sports medicine: An evidence-based approach","volume":"3","author":"Nguyen","year":"2011","journal-title":"PM R."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S1474-4422(16)30231-9","article-title":"Carpal tunnel syndrome: Clinical features, diagnosis, and management","volume":"15","author":"Padua","year":"2016","journal-title":"Lancet. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2296-11-54","article-title":"Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice","volume":"11","author":"Peters-Veluthamaningal","year":"2010","journal-title":"BMC Fam. Pract."},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bpobgyn.2020.06.002","article-title":"The pharmacodynamics and safety of progesterone","volume":"69","author":"Piette","year":"2020","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12891-018-1963-4","article-title":"Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial","volume":"19","author":"Raeissadat","year":"2018","journal-title":"BMC Musculoskelet. Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/ane.12739","article-title":"Randomized controlled trial of local progesterone vs corticosteroid injection for carpal tunnel syndrome","volume":"136","author":"Raeissadat","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"B35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jhsa.2019.02.007","article-title":"Comparison of ultrasound-guided versus landmark-based corticosteroid injection for carpal tunnel syndrome: A prospective randomized trial","volume":"44","author":"Roh","year":"2019","journal-title":"J. Hand Surg. Am."},{"key":"B36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: An overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1007\/s10067-019-04719-7","article-title":"Platelet-rich plasma in treatment of patients with idiopathic carpal tunnel syndrome","volume":"38","author":"Senna","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/term.2950","article-title":"Comparison of perineural platelet-rich plasma and dextrose injections for moderate carpal tunnel syndrome: A prospective randomized, single-blind, head-to-head comparative trial","volume":"13","author":"Shen","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/s0736-4679(99)00030-x","article-title":"The carpal tunnel syndrome","volume":"17","author":"Sternbach","year":"1999","journal-title":"J. Emerg. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1177\/0363546511417792","article-title":"Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma","volume":"39","author":"Sundman","year":"2011","journal-title":"Am. J. Sports Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.2105\/ajph.84.11.1846","article-title":"The US prevalence of self-reported carpal tunnel syndrome: 1988 national health interview survey data","volume":"84","author":"Tanaka","year":"1994","journal-title":"Am. J. Public Health"},{"key":"B42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/2000656X.2016.1260025","article-title":"Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome","volume":"51","author":"Uzun","year":"2017","journal-title":"J. Plast. Surg. Hand Surg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/2047487318767199","article-title":"Ranking of the most effective treatments for cardiovascular disease using SUCRA: Is it as sweet as it appears?","volume":"25","author":"Wang","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41598-017-00224-6","article-title":"Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.mayocp.2017.05.025","article-title":"Six-month efficacy of perineural dextrose for carpal tunnel syndrome: A prospective, randomized, double-blind, controlled trial","volume":"92","author":"Wu","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ana.25332","article-title":"Randomized double-blinded clinical trial of 5% dextrose versus triamcinolone injection for carpal tunnel syndrome patients","volume":"84","author":"Wu","year":"2018","journal-title":"Ann. Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5604\/15093492.1232629","article-title":"Carpal tunnel syndrome: Symptoms, causes and treatment options. Literature reviev","volume":"19","author":"Zamborsky","year":"2017","journal-title":"Ortop. Traumatol. Rehabil."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.906075\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T04:32:19Z","timestamp":1668054739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.906075\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":46,"alternative-id":["10.3389\/fphar.2022.906075"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.906075","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"article-number":"906075"}}